{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:25:11Z","timestamp":1792621511188,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02158","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T07:13:13Z","timestamp":1598598793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia"],"prefix":"10.3389","volume":"11","author":[{"given":"Stefania","family":"Fiorcari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vallerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Scarf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Barozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Maccaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis.","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007229","article-title":"Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing.","volume":"14","author":"Rosowski","year":"2018","journal-title":"PLoS Pathog."},{"key":"B3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","article-title":"Aspergillus fumigatus morphology and dynamic host interactions.","volume":"15","author":"van de Veerdonk","year":"2017","journal-title":"Nat Rev Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.blre.2018.04.007","article-title":"Infections in patients with chronic lymphocytic leukaemia: mitigating risk in the era of targeted therapies.","volume":"32","author":"Teh","year":"2018","journal-title":"Blood Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.intimp.2013.05.021","article-title":"Tumor-induced host immunosuppression: special focus on CLL.","volume":"17","author":"Cutucache","year":"2013","journal-title":"Int Immunopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3324\/haematol.2012.073080","article-title":"The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.","volume":"98","author":"Maffei","year":"2013","journal-title":"Haematologica."},{"key":"B7","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.","volume":"96","author":"Burger","year":"2000","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3109\/10428194.2014.991731","article-title":"Nurse like cells: chronic lymphocytic leukemia associated macrophages.","volume":"56","author":"Boissard","year":"2015","journal-title":"Leuk Lymphoma."},{"key":"B9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2141.2011.08747.x","article-title":"Nurse-like cells show deregulated expression of genes involved in immunocompetence.","volume":"154","author":"Bhattacharya","year":"2011","journal-title":"Br J Haematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bcmd.2012.12.003","article-title":"Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?","volume":"50","author":"Filip","year":"2013","journal-title":"Blood Cells Mol Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"65968","DOI":"10.18632\/oncotarget.11782","article-title":"Ibrutinib modifies the function of monocyte\/macrophage population in chronic lymphocytic leukemia.","volume":"7","author":"Fiorcari","year":"2016","journal-title":"Oncotarget."},{"key":"B12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.15252\/emmm.201404556","article-title":"Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus.","volume":"7","author":"Herbst","year":"2015","journal-title":"EMBO Mol Med."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93156","article-title":"Immunity against fungi.","volume":"2","author":"Lionakis","year":"2017","journal-title":"JCI Insight."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"E646","DOI":"10.1002\/ajh.24890","article-title":"Ibrutinib-associated Pneumocystis jirovecii pneumonia.","volume":"92","author":"Lee","year":"2017","journal-title":"Am J Hematol."},{"key":"B16","first-page":"4323","article-title":"Ibrutinib: a risk factor for invasive fungal infections?","volume":"130","author":"Ruchlemer","year":"2017","journal-title":"Blood."},{"key":"B17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/15384047.2018.1508622","article-title":"Is ibrutinib associated with disseminated cryptococcosis with CNS involvement?","volume":"20","author":"Abid","year":"2018","journal-title":"Cancer Biol Ther."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0157-x","article-title":"Targeting neoplastic B cells and harnessing microenvironment: the \u201cdouble face\u201d of ibrutinib and idelalisib.","volume":"8","author":"Maffei","year":"2015","journal-title":"J Hematol OncolJ Hematol Oncol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.74","article-title":"Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients.","volume":"5","author":"Boissard","year":"2015","journal-title":"Blood Cancer J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1509981","article-title":"Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia.","volume":"374","author":"Byrd","year":"2016","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110451","article-title":"Acalabrutinib in treatment-naive (TN) chronic lymphocytic leukemia (CLL): updated results from the phase 1\/2 ACE-CL-001 study.","volume":"132","author":"Byrd","year":"2018","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-111919","article-title":"Partial reconstitution of humoral and cellular immunity in patients with chronic lymphocytic leukemia treated with acalabrutinib.","volume":"132","author":"Pleyer","year":"2018","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.","volume":"117","author":"Herman","year":"2011","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1182\/blood-2017-12-823393","article-title":"Ibrutinib blocks Btk-dependent NF-\u03baB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis.","volume":"132","author":"Bercusson","year":"2018","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages.","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood-2009-12-258186","article-title":"The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression.","volume":"117","author":"S\u00e1nchez-Mart\u00edn","year":"2011","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/cyto.1997.0249","article-title":"M-CSF: haematopoietic growth factor or inflammatory cytokine?","volume":"10","author":"Fixe","year":"1998","journal-title":"Cytokine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1182\/blood-2014-02-548610","article-title":"Ibrutinib inhibits BCR and NF-\u03baB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.","volume":"123","author":"Herman","year":"2014","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/13543784.2018.1404027","article-title":"Bruton\u2019s tyrosine kinase inhibitors: first and second generation agents for patients with chronic lymphocytic leukemia (CLL).","volume":"27","author":"Thompson","year":"2018","journal-title":"Expert Opin Investig Drugs."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1812836","article-title":"Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL.","volume":"379","author":"Woyach","year":"2018","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1182\/blood-2016-06-722991","article-title":"Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib.","volume":"128","author":"Ahn","year":"2016","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rmcr.2017.03.011","article-title":"Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia.","volume":"21","author":"Arthurs","year":"2017","journal-title":"Respir Med Case Rep."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100635","article-title":"Immunomodulatory effect of ibrutinib: reducing the barrier against fungal infections.","volume":"40","author":"Maffei","year":"2019","journal-title":"Blood Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4049\/jimmunol.181.1.288","article-title":"Dual functions of Bruton\u2019s tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis.","volume":"181","author":"Jongstra-Bilen","year":"2008","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1074\/jbc.M115.687251","article-title":"Analysis of the effects of the Bruton\u2019s tyrosine kinase (Btk) inhibitor ibrutinib on monocyte Fc\u03b3 receptor (Fc\u03b3R) function.","volume":"291","author":"Ren","year":"2016","journal-title":"J Biol Chem."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003446","article-title":"Bruton\u2019s Tyrosine Kinase (BTK) and Vav1 contribute to Dectin1-dependent phagocytosis of Candida albicans in macrophages.","volume":"9","author":"Strijbis","year":"2013","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1073\/pnas.1424907112","article-title":"Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and Btk.","volume":"112","author":"Feng","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/leu.2015.316","article-title":"BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/leu.2016.129","article-title":"Decrease in total protein level of Bruton\u2019s tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes.","volume":"30","author":"Cervantes-Gomez","year":"2016","journal-title":"Leukemia."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110395","article-title":"Acalabrutinib in patients with relapsed\/refractory (R\/R) and high-risk, treatment-naive (TN) chronic lymphocytic leukemia (CLL).","volume":"132","author":"Sun","year":"2018","journal-title":"Blood."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1172\/JCI89756","article-title":"Ibrutinib treatment improves T cell number and function in CLL patients.","volume":"127","author":"Long","year":"2017","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/ciy175","article-title":"Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer.","volume":"67","author":"Varughese","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02158\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T07:13:18Z","timestamp":1598598798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02158\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2020.02158"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02158","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"article-number":"2158"}}